Relationship between the rs1414334 C/G polymorphism in the HTR2C gene and smoking in patients treated with atypical antipsychotics
DOI:
https://doi.org/10.20882/adicciones.876Keywords:
Smoking, Pharmacogenetics, Alleles, PsychiatryAbstract
An association has been found between the C allele of the rs1414334 polymorphism in the HTR2C gene and the metabolic syndrome in psychiatric patients. However, no study has yet evaluated whether this allele is associated with smoking. To assess this issue, therefore, we performed a cross-sectional study with a sample of 166 adult patients treated with atypical antipsychotics in 2012-2013 in a region of Spain. The primary variable was the presence of the C allele of the rs1414334 polymorphism in the HTR2C gene. Secondary variables were the number of pack-years (number of cigarettes per day x number of smoking years ÷ 20), age, gender, schizophrenia, years since diagnosis, metabolic syndrome criteria and SCORE. A stepwise binary logistic regression model was constructed to determine associations between primary and secondary variables and their area under the ROC curve (AUC) was calculated. Of the total sample, 33 patients (19.9%) had the C allele of the polymorphism analyzed. Mean cigarette consumption was 11.6 pack-years. The multivariate analysis showed the following factors as associated with the polymorphism: higher cigarette consumption, being a woman, and not having abdominal obesity. The AUC was 0.706. An association was found between increased cigarette consumption over the years and the presence of the C allele of the rs1414334 polymorphism in the HTR2C gene.References
American Diabetes Association. (2012). Standards of medical care in diabetes–2012. Diabetes Care, 35, S11-63. doi:10.2337/dc12-s011.
American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington: American Psychiatric Press.
Azrak, C., Palazón-Bru, A., Baeza-Díaz, M. V., Folgado-De la Rosa, D. M., Hernández-Martínez, C., Martínez-Toldos, J. J. y Gil-Guillén, V. F. (2015). A predictive screening tool to detect diabetic retinopathy or macular edema in primary health care: construction, validation and implementation on a mobile application. PeerJ, 3, e1404. doi:10.7717/peerj.1404.
Barrot, C., Sánchez, C., Abellana, R., Ortega, M. y Gené, M. (2013). Polimorfismos genéticos como indicadores de la vulnerabilidad individual a la adicción al tabaco. Medicina Clínica (Barcelona), 140, 49-52. doi:10.1016/j. medcli.2012.05.041.
Conroy, R. M., Pyörälä, K., Fitzgerald, A. P., Sans, S., Menotti, A., De Backer, G., Graham, I. M.; SCORE project group. (2003). Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal, 24, 987-1003. doi:10.1016/ S0195-668X(03)00114-3.
Fletcher, P. J., Lê, A. D. y Higgins, G. A. (2008). Serotonin receptors as potential targets for modulation of nicotine use and dependence. Progress in Brain Research, 172, 361-383. doi:10.1016/S0079-6123(08)00918-7.
Gregoor, J. G., Mulder, H., Cohen, D., van Megen, H. J., Egberts, T. C., Heerdink, E. R. y van der Weide, J. (2010). Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medication. Journal of Clinical Psychopharmacology, 30, 702-705. doi:10.1097/JCP.0b013e3181fa05a2.
Grundy, S. M., Brewer, H. B. Jr, Cleeman, J. I., Smith, S. C. Jr y Lenfant, C; American Heart Association; National Heart, Lung, and Blood Institute. (2004). Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation, 109, 433-438. doi:10.1161/01. CIR.0000111245.75752.C6.
Guy, E. G. y Fletcher, P. J. (2014). Responding for a conditioned reinforcer, and its enhancement by nicotine, is blocked by dopamine receptor antagonists and a 5-HT(2C) receptor agonist but not by a 5-HT(2A) receptor antagonist. Pharmacology Biochemistry and Behavior, 125, 40-47. doi:10.1016/j.pbb.2014.08.006.
Gutiérrez-Gómez, T., Cortés, E., Palazón-Bru, A., Peñarrieta- de Córdova, I., Gil-Guillén, V. F. y Ferrer-Diego, R. M. (2015). Six simple questions to detect malnutrition or malnutrition risk in elderly women. PeerJ, 3, e1316. doi:10.7717/peerj.1316.
Hanley, J. A. y McNeil, B. J. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143, 29-36. doi:10.1148/radiology. 143.1.7063747.
Hoekstra, P. J., Troost, P. W., Lahuis, B. E., Mulder, H., Mulder, E. J., Franke, B., Buitelaar, J. K., Anderson, G. M., Scahill, L. y Minderaa, R. B. (2010). Risperidone-induced weight gain in referred children with autism spectrum disorders is associated with a common polymorphism in the 5-hydroxytryptamine 2C receptor gene. Journal of Child and Adolescent Psychopharmacology, 20, 473-477. doi:10.1089/cap.2009.0071.
Houston, J. P., Kohler, J., Bishop, J. R., Ellingrod, V. L., Ostbye, K. M., Zhao, F., Conley, R. R., Poole Hoffmann, V. y Fijal, B. A. (2012). Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia. Journal of Clinical Psychiatry, 73, 1077-1086. doi:10.4088/JCP.11m06916.
Klemettilä, J. P., Kampman, O., Seppälä, N., Viikki, M., Hämäläinen, M., Moilanen, E., Mononen, N., Lehtimäki, T. y Leinonen, E. (2015). Association study of the HTR2C, leptin and adiponectin genes and serum marker analyses in clozapine treated long-term patients with schizophrenia. European Psychiatry, 30, 296-302. doi:10.1016/j.eurpsy.2014.08.006.
López-Bru, D., Palazón-Bru, A., Folgado-de la Rosa, D. M. y Gil-Guillén, V. F. (2015). Scoring System for Mortality in Patients Diagnosed with and Treated Surgically for Differentiated Thyroid Carcinoma with a 20-Year Follow- Up. PLoS One, 10, e0128620. doi:10.1371/journal. pone.0128620.
Ma, X., Maimaitirexiati, T., Zhang, R., Gui, X., Zhang, W., Xu, G. y Hu, G. (2014). HTR2C polymorphisms, olanzapine- induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta- analysis. International Journal of Psychiatry in Clinical Practice, 18, 229-242. doi:10.3109/13651501.2014.9 57705.
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Williams, B. (2007). 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension, 25, 1105-1187. doi:10.1097/HJH. 0b013e3281fc975a.
McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., Lieberman, J. A. (2005). Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research, 80, 19-32. doi:10.1016/j.schres.2005.07.014.
Mulder, H., Franke, B., van der-Beek van der, A. A., Arends, J., Wilmink, F. W., Scheffer, H. y Egberts, A. C. (2007). The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia. Journal of Clinical Psychopharmacology, 27, 338-343. doi:10.1097/JCP.0b013e3180a76dc0.
Mulder, H., Franke, B., van der-Beek van der, A. A., Arends, J., Wilmink, F. W., Egberts, A. C. y Scheffer, H. (2007). The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study. Pharmacogenomics Journal, 7, 318-324. doi:10.1038/sj.tpj.6500422.
Mulder, H., Cohen, D., Scheffer, H., Gispen-de Wied, C., Arends, J., Wilmink, F. W., Egberts, A. C. (2009). HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study. Journal of Clinical Psychopharmacology, 29, 16-20. doi:10.1097/JCP.0b013e3181934462.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106, 3143-3421.
National Institutes of Health. (1998). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—The Evidence Report. Obesity Research, 6, 51S-209S. doi:10.1002/j.1550-8528.1998.tb00690.x.
Newcomer, J. W. y Hennekens, C. H. (2007). Severe mental illness and risk of cardiovascular disease. JAMA, 298, 1794-1796. doi:10.1001/jama.298.15.1794.
Prescott, E., Hippe, M., Schnohr, P., Hein, H. O. y Vestbo, J. (1998). Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ, 316, 1043-1047. doi:10.1136/bmj.316.7137.1043.
Ramírez-Prado, D., Palazón-Bru, A., Folgado-de la Rosa, D. M., Carbonell-Torregrosa, M. Á., Martínez-Díaz, A. M., Martínez-St John, D. R. y Gil-Guillén, V. F. (2015). A four-year cardiovascular risk score for type 2 diabetic inpatients. PeerJ, 3, e984. doi:10.7717/peerj.984.
Rico-Gomis, J. M., Palazón-Bru, A., Triano-García, I., Mahecha- García, L. F., García-Monsalve, A., Navarro-Ruiz, A., …Gil-Guillén, V. F. (2016). Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics. PeerJ, 4, e2163. doi:10.7717/peerj.2163.
Risselada, A. J., Vehof, J., Bruggeman, R., Wilffert, B., Cohen, D., Al Hadithy, A. F., … Mulder, H. (2012). Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study. Pharmacogenomics Journal, 12, 62- 67. doi:10.1038/tpj.2010.66.
Saccone, S. F., Hinrichs, A. L., Saccone, N. L., Chase, G. A., Konvicka, K., Madden, P. A., … Bierut, L. J. (2007). Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Human Molecular Genetics, 16, 36-49. doi:10.1093/hmg/ddl438.
Saha, S., Chant, D. y McGrath, J. (2007). A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Archives of General Psychiatry, 64, 1123-1131. doi:10.1001/archpsyc.64.10.1123.
San, L., Arranz, B., Arrojo, M., Becoña, E., Bernardo, M., Caballero, L., …Zorrilla, I. (2016). Clinical guideline for the treatment of dual pathology in the adult population. Adicciones, 28, 3-5. doi:10.20882/adicciones.784.
The Weizmann Institute of Science Crown Human Genome Centre. (2014). GeneCards. Retrieved at http:// www.genecards.org/cgi bin/carddisp.pl?gene=HTR2C.
Verde, Z., Santiago, C., Rodríguez González-Moro, J. M., de Lucas Ramos, P., López Martín, S., Bandrés, F., … Gómez-Gallego, F. (2011). ‘Smoking genes’: a genetic association study. PLoS One, 6, e26668. doi:10.1371/ journal.pone.0026668.
Walton, R., Johnstone, E., Munafò, M., Neville, M. y Griffiths, S. (2001). Genetic clues to the molecular basis of tobacco addiction and progress towards personalized therapy. Trends in Molecular Medicine, 7, 70-76. doi:10.1016/S1471-4914(01)01915-3.
Wilson, P. W., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H. y Kannel, W. B. (1998). Prediction of coronary heart disease using risk factor categories. Circulation, 97, 1837-1847. doi:10.1161/01.CIR.97.18.1837.
